The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system

Neuroscience and Behavioral Physiology

Volumn 34, Issue 4, 2004, Pages 399-405

  Levitskaya, N G ^a,b   Sebentsova, E A ^a,b   Andreeva, L A ^a,b   Alfeeva, L Yu ^a,b   Kamenskii, A A ^a,b   Myasoedov, N F ^a,b  

^a INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

ACTH fragments; Dopaminergic system; MPTP; Rats; Semax

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CORTICOTROPIN DERIVATIVE; CORTICOTROPIN[4-10]; NEUROTOXIN; SEMAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ACTIVITY; MALE; MOTOR DYSFUNCTION; NEUROMODULATION; NEUROPROTECTION; NEUROTOXICITY; NEUROTROPISM; NONHUMAN; OPEN FIELD TEST; RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY; DISEASE MODELS, ANIMAL; DOPAMINE; EXPLORATORY BEHAVIOR; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; PEPTIDE FRAGMENTS; RATS; STATISTICS; STATISTICS, NONPARAMETRIC; SUBSTANTIA NIGRA;

EID: 4344648811     PISSN: 00970549     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEAB.0000018752.59465.28     Document Type: Article

References (21)

1. I. P. Ashmarin, V. N. Nezavibat'ko, N. F. Myasoedov, A. A. Kamenskii, I. A. Grivennikov, M. A. Ponomareva-Stepnaya, L. A. Andreeva, A. Ya. Kaplan, V. B. Kosheleva, and T. V. Ryasina, "A nootropic analog of adrenocorticotrophic hormone 4-10 - Semax," Zh. Vyssh. Nerv. Deyat., 47, No. 2, 420-430 (1997).
2. I. A. Grivennikov, O. V. Dolotov, and Yu. I. Gol'dina, Mol. Biologiya, 33, No. 1, 120-126 (1999).
3. E. I. Gusev, V. I. Skvortsova, N. F. Myasoedov, E. Yu. Zhuravleva, and A. V. Vanichkin, Zh. Nevropatol. Psikhiatr S. S. Korsakova, 97, No. 6, 26 34 (1997).
4. A. A. Kamenskii, L. V. Antonova, and N. G. Levitskaya, "The actions of different doses of ACTH fragments on white rats," Fiziol. Zh. SSSR, 66, No. 10, 1549-1553 (1980).
5. A. A. Kamenskii, O. G. Voskresenskaya, V. A. Dubynin, and N. G. Levitskaya, "Relationship between the physiological effects of a series of neuropeptides and the route of administration," Ros. Fiziol. Zh. im. I. M. Sechenova, 87, No. 11, 1493-1501 (2001).
6. F. J. Antonawich, E. C. Azmitia, and F. L. Strand, "Rapid neurotrophic actions of synapse ACH/MSH(4-9) analogue after nigrostriatal 6-OHDA lesioning," Peptides, 14, No. 6, 1317-1324 (1993).
7. F. J. Antonawich, E. C. Azmitia, H. K. Kramer, and F. L. Strand, "Specificity versus redundancy of melanocortins in nerve regeneration," Ann. N. Y. Acad. Sci., 739, 60-73 (1994).
8. I. P. Ashmarin, V. N. Nezavibatko, N. G. Levitskaya, V. B. Koshelev, and A. A. Kamensky, "Design and investigation of an ACTH(4-10) analogue lacking D-amino acids and hydrophobic radicals," Neurosci. Res. Commun., 16, No. 2, 105-112 (1995).
9. D. de Wied, "Neuropeptides in learning and memory processes," Behav. Brain Res., 83, 83-90 (1997).
10. P. E. Gold and R. L. Delanoy, "ACTH modulation of memory storage processing," in: Endogenous Peptides and Learning and Memory Processes, Academic Press (1981), pp. 79-97.
11. H. M. Greven and D. de Wied, "Influence of peptides structurally related to ACTH and MSH on active avoidance behaviour in rats. A structure-activity relationship study," Front. Horm. Res., 4, 140-152 (1977).
12. E. M. Hol, W. H. Gispen, and P. R. Bar, "ACTH-related peptides: receptor and signal transduction systems involved in their neurotrophic actions," Peptides, 16, No. 5, 979-993 (1995).
13. O. Hornykiewicz and S. J. Kish, "Biochemical pathophysiology of Parkinson's disease," Adv. Neurol., 45, 19-34 (1987).
14. I. J. Kopin, "Features of dopaminergic neurotoxin MPTP," Ann. N. Y. Acad. Sci., 648, 96-104 (1992).
15. M. I. Shadrina, O. V. Dolotov, I. A. Grivennikov, P. A. Solminsky, L. A. Andreeva, L. S. Inozemtseva, S. A. Limborska, and N. F. Myasoedov, "Rapid induction of neurotrophin mRNAs in rat glial cell cultures significantly Semax, an adrenocorticotrophic hormone analog," Neurosci. Lett., 308, 115-118 (2001).
16. T. Shimura, S. Tabata, and S. Hayashi, "Brain transfer of a new neuromodulating activity analog, Ebiratide, in rats," Peptides, 12, No. 3, 509-512 (1991).
17. M. M. Spruijt, "Effects of the ACTH(4-9) analog ORG 2766 on brain plasticity: modulation of excitatory neurotransmission?" Psychoneuroendocrinology, 17, No. 4, 315-325 (1992).
18. F. L. Strand, K. J. Rose, J. A. King, A. C. Segarra, and L. A. Zuccarelli, "ACTH modulation of nerve development and regeneration," Prog. Neurobiol., 33, No. 1, 45-85 (1989).
19. F. L. Strand, L. A. Zuccarelli, K. A. Williams, S. J. Lee, T. S. Lee, F. J. Antonawich, and S. E. Alves, "Melanotropins as growth factors," Ann. N. Y. Acad. Sci., 680, 29-50 (1993).
20. F. L. Strand, C. Saint-Come, T. S. Lee, S. J. Lee, J. Kume, and L. A. Zuccarelli, "ACTH/MSH analog BIM 22015 aids regeneration via neurotropic and myotropic attributes," Peptides, 14, No. 2, 287-296 (1993).
21. F. L. Strand, "New vistas for melanocortins. Finally, an explanation for their pleiotropic functions," Ann. N.Y. Acad. Sci.,